Jane Henderson
Chief Financial Officer · 8 filings · Latest: Sep 3, 2026
Apogee Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APGE | Jane Henderson | Chief Financial Officer | May 1, 2026 | Sale | $82.04 | 2,000 | $164.1K | 173,371 | |
APGE | JANE HENDERSON | — | May 1, 2026 | Proposed Sale | $82.89 | 2,000 | $165.8K | — | |
APGE | Jane Henderson | Chief Financial Officer | Apr 16, 2026 | Sale | $90.00 | 2,000 | $180.0K | 175,371 | |
APGE | Jane Henderson | Chief Financial Officer | Apr 1, 2026 | Sale | $85.01 | 2,000 | $170.0K | 177,371 | |
APGE | Jane Henderson | Chief Financial Officer | Mar 25, 2026 | Sale | $85.00 | 2,000 | $170.0K | 179,371 | |
APGE | JANE HENDERSON | — | Mar 25, 2026 | Proposed Sale | $73.00 | 6,000 | $438.0K | — | |
APGE | Jane Henderson | Chief Financial Officer | Mar 2, 2026 | Sale | $70.22 | 2,000 | $140.4K | 181,371 | |
APGE | Jane Henderson | Chief Financial Officer | Feb 2, 2026 | Sale | $65.81 | 2,000 | $131.6K | 183,371 | |
APGE | JANE HENDERSON | — | Jan 2, 2026 | Proposed Sale | $75.48 | 12,000 | $905.8K | — | |
APGE | JANE HENDERSON | — | Dec 19, 2025 | Proposed Sale | $77.35 | 1,500 | $116.0K | — | |
APGE | JANE HENDERSON | — | Dec 4, 2025 | Proposed Sale | $74.55 | 1,500 | $111.8K | — | |
APGE | JANE HENDERSON | — | Nov 25, 2025 | Proposed Sale | $67.85 | 1,500 | $101.8K | — | |
APGE | JANE HENDERSON | — | Nov 14, 2025 | Proposed Sale | $62.97 | 2,000 | $125.9K | — | |
APGE | JANE HENDERSON | — | Nov 11, 2025 | Proposed Sale | $56.77 | 1,000 | $56.8K | — | |
AKRO | JANE HENDERSON | — | Aug 12, 2025 | Proposed Sale | $47.46 | 3,000 | $142.4K | — | |
APGE | JANE V HENDERSON | — | Aug 23, 2024 | Proposed Sale | $48.26 | 6,000 | $289.6K | — |